Project Details
Description
Project 1: Diagnostic and prognostic biomarkers in DLB and PDD (lead: Dag Aarsland)
Project 2: Understanding Emergency Department attendance among people with dementia approaching the end of life (lead: Katherine Sleeman)
Project 3: Biomarkers for clinical trials to prevent Alzheimer’s disease in Down syndrome (lead: Andre Strydom)
Project 2: Understanding Emergency Department attendance among people with dementia approaching the end of life (lead: Katherine Sleeman)
Project 3: Biomarkers for clinical trials to prevent Alzheimer’s disease in Down syndrome (lead: Andre Strydom)
| Status | Finished |
|---|---|
| Effective start/end date | 1/09/2019 → 31/07/2024 |
Funding
- Alzheimer's Society: £225,000.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.